![]() |
市场调查报告书
商品编码
1930037
外科缝合线市场规模、占有率、成长及全球产业分析:按类型、应用和地区划分的洞察与预测(2025-2034)Surgical Sutures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034 |
||||||
由于手术数量的增加、慢性病盛行率的上升以及缝合技术的不断进步,全球外科缝合线市场正经历稳定成长。 2025年,全球外科缝线市场规模为60.3亿美元。预计该市场将从2026年的64.2亿美元成长到2034年的115.2亿美元,在预测期(2026-2034年)内,复合年增长率(CAGR)为7.57%。
预计北美将在2025年以39.44%的市场占有率引领外科缝合线市场,这主要得益于该地区较高的手术量、先进的医疗基础设施以及主要市场参与者的强大影响力。
外科缝合线是一种医疗器械,用于在手术期间或手术后闭合伤口和结扎血管。这些产品广泛应用于各种手术,从剖腹产、关节置换和心血管手术等大型手术到牙科和眼科手术等小型手术。交通事故、骨科损伤和慢性疾病的日益增多,正推动全球外科手术数量的显着增长,从而带动了对外科缝合线的需求。
市场驱动因素
手术数量不断增加
骨科、心血管、妇科和整形手术数量的不断增长是推动市场成长的主要因素。例如,根据美国风湿病学会(2023年2月)的数据,美国每年约进行79万例膝关节置换手术和45万例髋关节置换手术。
此外,根据美国疾病管制与预防中心 (CDC) 的数据,2021 年美国共记录了 1,174,545 例剖腹产手术,占所有分娩的 32.1%。老年人口的增长,尤其是易患关节炎、骨折和心血管疾病的老年人口,进一步推高了手术干预率,从而促进了市场扩张。
缝合线技术进步
先进缝合线的引入,例如无结缝合线、弹性缝合线和生物复合缝合线,改善了手术效果,并促进了其应用。这些缝合线能够加速伤口癒合,降低感染风险,并提高抗拉强度。持续的研发投入和创新产品的监管审批正在对市场成长产生积极影响。
市场趋势
先进智慧缝线的引入
市场的主要趋势之一是采用技术先进的无结缝合线,以满足尚未满足的临床需求。这些缝合线可以输送药物、检测感染并支持有效的伤口闭合。
例如,美国食品药物管理局 (FDA) 已授予多种无结缝合系统 510(k) 许可,包括 Anika Therapeutics 的 X-Twist 和 Smith & Nephew 的 HELICOIL 无结缝合系统。这些进步使企业能够巩固其市场地位,同时扩展其产品组合。
限制因子
来自其他伤口闭合产品的竞争
手术缝合器等其他伤口护理产品的激增对市场成长构成了挑战。缝合器可以加快伤口闭合速度并缩短手术时间。此外,对缝线相关手术部位感染 (SSI) 的担忧以及新兴经济体缺乏报销政策可能会限制其应用。根据美国国家生物技术资讯中心 (NCBI) 的数据,每年约有 5% 的手术患者发生 SSI,这会影响外科医生在某些手术中选择缝线。
依产品类型
此市场细分分为可吸收缝线和不可吸收缝线。
由于其癒合速度快、抗拉强度高且减少拆线次数,可吸收缝线细分市场预计将在 2026 年占 64.30% 的市场占有率。监管支持进一步巩固了该细分市场的主导地位。
依型态
依型态,市场分为合成缝线和天然缝线。
由于合成缝合线过敏反应发生率低且在医疗专业人员中普及率高,预计到2026年,合成缝合线市场占有率将达到78.31%。
依应用领域划分
骨科领域在2026年占市场主导地位,市占率为27.40%,主要得益于关节置换和骨折修復手术的增加。妇科和心臟科领域也贡献显着,这主要归功于剖腹产和搭桥手术的增加。
依最终使用者划分
医院和门诊手术中心(ASC)在2026年占市场主导地位,市场占有率为71.15%,这主要得益于其手术量大、设施先进以及外科医生技术精湛。
The global surgical sutures market is witnessing steady growth driven by the rising number of surgical procedures, increasing prevalence of chronic diseases, and continuous advancements in suturing technologies. In 2025, the global surgical sutures market size was valued at USD 6.03 billion. The market is projected to grow from USD 6.42 billion in 2026 to USD 11.52 billion by 2034, registering a CAGR of 7.57% during the forecast period (2026-2034).
North America dominated the surgical sutures market with a 39.44% share in 2025, supported by a high volume of surgeries, advanced healthcare infrastructure, and strong presence of key market players.
Surgical sutures are medical devices used to close wounds and ligate blood vessels during or after surgical procedures. These products are extensively used in major surgeries such as cesarean sections, joint replacements, cardiovascular surgeries, and minor procedures including dental and ophthalmic surgeries. The growing incidence of road accidents, orthopedic injuries, and chronic disorders has significantly increased surgical volumes worldwide, thereby boosting demand for surgical sutures.
Market Drivers
Rising Number of Surgical Procedures
The increasing number of orthopedic, cardiovascular, gynecological, and cosmetic surgeries is a major factor driving market growth. For instance, data from the American College of Rheumatology (February 2023) indicates that approximately 790,000 knee replacement and 450,000 hip replacement surgeries are performed annually in the U.S.
Additionally, according to the CDC, 1,174,545 cesarean deliveries were recorded in the U.S. in 2021, accounting for 32.1% of all births. The expanding geriatric population, which is more prone to arthritis, fractures, and cardiovascular conditions, is further increasing surgical intervention rates and supporting market expansion.
Technological Advancements in Sutures
The introduction of advanced sutures, including knotless, elastic, and bio-composite sutures, is improving surgical outcomes and driving adoption. These sutures enable faster wound healing, reduced infection risk, and enhanced tensile strength. Continuous R&D investments and regulatory approvals for innovative products are positively influencing market growth.
Market Trends
Introduction of Advanced and Smart Sutures
One of the key trends in the market is the adoption of knotless and technologically advanced sutures designed to address unmet clinical needs. These sutures can deliver drugs, detect infections, and support efficient wound closure.
For instance, the U.S. FDA granted 510(k) clearance to several knotless suture systems, including Anika Therapeutics' X-Twist and Smith & Nephew's HELICOIL knotless sutures. Such advancements are enabling companies to strengthen their market position while expanding product portfolios.
Restraining Factors
Competition from Alternative Wound Closure Products
The availability of alternative wound care products such as surgical staplers poses a challenge to market growth. Staplers offer faster wound closure and reduced operation time. In addition, concerns related to surgical site infections (SSIs) associated with sutures and lack of reimbursement policies in emerging economies may limit adoption. According to NCBI data, approximately 5% of surgical patients develop SSIs annually, which impacts surgeon preference for sutures in certain procedures.
By Product Type
The market is segmented into absorbable and non-absorbable sutures.
The absorbable segment dominated with a 64.30% share in 2026, owing to faster healing, high tensile strength, and reduced need for stitch removal. Regulatory support further strengthens this segment's dominance.
By Form
Based on form, the market is divided into synthetic and natural sutures.
The synthetic segment accounted for 78.31% market share in 2026, attributed to lower hypersensitivity reactions and higher adoption by healthcare professionals.
By Application
The orthopedics segment led the market with a 27.40% share in 2026, driven by a rising number of joint replacement and fracture repair surgeries. Gynecology and cardiology also contribute significantly due to increasing cesarean and bypass procedures.
By End User
The hospitals & ASCs segment dominated with a 71.15% share in 2026, supported by high surgical volumes, advanced facilities, and skilled surgeons.
Competitive Landscape
Key players include B. Braun SE, Ethicon U.S. LLC, Medtronic, Smith & Nephew, and Coloplast A/S. These companies focus on product innovation, capacity expansion, and strategic launches to strengthen their global presence.
Conclusion
In conclusion, the global surgical sutures market is projected to grow steadily from USD 6.03 billion in 2025 to USD 11.52 billion by 2034. Rising surgical volumes, technological advancements in suturing devices, and increasing geriatric population are the key growth drivers. Although competition from alternative wound closure products and infection-related concerns pose challenges, continuous innovation and expanding healthcare infrastructure worldwide are expected to sustain long-term market growth.
Segmentation
By Product Type
By Form
By Application
By End-user
By Geography